Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.5201
-0.0001 (-0.02%)
At close: Sep 8, 2026, 4:00 PM EDT
0.5201
-0.0001 (-0.02%)
Pre-market: Sep 9, 2026, 8:56 AM EDT
Dyadic International Employees
Dyadic International had 5 employees as of December 31, 2025. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
$760,447
Profits / Employee
-$1,524,368
Market Cap
18.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | -1 | -16.67% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2021 | 7 | 1 | 16.67% |
| Dec 31, 2020 | 6 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Enlivex | 34 |
| Cerenome | 28 |
| Lipocine | 14 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Allarity Therapeutics | 8 |
| Neuphoria Therapeutics | 8 |
| Pasithea Therapeutics | 5 |
DYAI News
- 13 days ago - Dyadic International Transcript: Q3 Investor Summit Group Virtual Conference 2026 - Transcripts
- 23 days ago - Dyadic International prices 3.625M shares at 79.5c in registered direct offering - TheFly
- 27 days ago - Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 27 days ago - Dyadic International Earnings Call Transcript: Q2 2026 - Transcripts
- 27 days ago - Dyadic International Earnings release: Q2 2026 - Filings
- 27 days ago - Dyadic International Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas - GlobeNewsWire
- 5 weeks ago - Dyadic enters commercial license agreement with European biotechnology company - TheFly